Connection

Miguel Abboud to Child, Preschool

This is a "connection" page, showing publications Miguel Abboud has written about Child, Preschool.
Connection Strength

1.749
  1. Emergence of gram-negative organisms as the cause of infections in patients with sickle cell disease. Pediatr Blood Cancer. 2021 01; 68(1):e28784.
    View in: PubMed
    Score: 0.108
  2. Standard management of sickle cell disease complications. Hematol Oncol Stem Cell Ther. 2020 Jun; 13(2):85-90.
    View in: PubMed
    Score: 0.104
  3. Acquired centromeric heteromorphism of chromosome 7 yields discordant results between fluorescent in situ hybridization and karyotype analysis in a child with severe congenital neutropenia. Pediatr Hematol Oncol. 2019 Oct; 36(7):432-437.
    View in: PubMed
    Score: 0.100
  4. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
    View in: PubMed
    Score: 0.097
  5. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
    View in: PubMed
    Score: 0.088
  6. Educational intervention to improve the health outcomes of children with sickle cell disease. J Pediatr Health Care. 2015 Jan-Feb; 29(1):54-60.
    View in: PubMed
    Score: 0.070
  7. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
    View in: PubMed
    Score: 0.060
  8. Cerebral infarction in children with sickle cell disease: a concise overview. Hemoglobin. 2011; 35(5-6):618-24.
    View in: PubMed
    Score: 0.058
  9. Predictors of bone loss in childhood hematologic malignancies: a prospective study. Osteoporos Int. 2012 Feb; 23(2):665-74.
    View in: PubMed
    Score: 0.056
  10. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010 Mar; 54(3):398-402.
    View in: PubMed
    Score: 0.052
  11. Iron deficiency in young Lebanese children: association with elevated blood lead levels. J Pediatr Hematol Oncol. 2008 May; 30(5):382-6.
    View in: PubMed
    Score: 0.046
  12. Prevention and management of strokes in patients with sickle cell disease. Curr Hematol Rep. 2006 Mar; 5(1):15-22.
    View in: PubMed
    Score: 0.039
  13. Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
    View in: PubMed
    Score: 0.036
  14. Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
    View in: PubMed
    Score: 0.030
  15. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 11; 68(11):e29210.
    View in: PubMed
    Score: 0.029
  16. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000 Nov; 111(2):482-90.
    View in: PubMed
    Score: 0.027
  17. Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon. PLoS One. 2020; 15(9):e0239258.
    View in: PubMed
    Score: 0.027
  18. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon. Clin Immunol. 2020 10; 219:108573.
    View in: PubMed
    Score: 0.027
  19. Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
    View in: PubMed
    Score: 0.027
  20. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemp Clin Trials. 2019 10; 85:105835.
    View in: PubMed
    Score: 0.025
  21. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenet Genomics. 2018 08; 28(8):189-195.
    View in: PubMed
    Score: 0.023
  22. Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.022
  23. Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.022
  24. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.021
  25. Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
    View in: PubMed
    Score: 0.021
  26. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group. Bone Marrow Transplant. 2017 Jan; 52(1):120-125.
    View in: PubMed
    Score: 0.020
  27. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Pediatr Blood Cancer. 2017 01; 64(1):146-150.
    View in: PubMed
    Score: 0.020
  28. Serum levels of GM-CSF are elevated in patients with thrombocytopenia. Br J Haematol. 1996 Feb; 92(2):486-8.
    View in: PubMed
    Score: 0.019
  29. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials. Hematol Oncol Stem Cell Ther. 2016 Mar; 9(1):20-5.
    View in: PubMed
    Score: 0.019
  30. Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
    View in: PubMed
    Score: 0.019
  31. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. N Engl J Med. 2016 Feb 18; 374(7):625-35.
    View in: PubMed
    Score: 0.019
  32. Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2167-71.
    View in: PubMed
    Score: 0.019
  33. Pain in children and adolescents with sickle cell anemia: a prospective study utilizing self-reporting. Am J Pediatr Hematol Oncol. 1994 Aug; 16(3):219-24.
    View in: PubMed
    Score: 0.018
  34. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug; 24(8):387-96.
    View in: PubMed
    Score: 0.018
  35. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12; 6(227):227ra33.
    View in: PubMed
    Score: 0.017
  36. Bone marrow transplantation for sickle cell disease. The United States experience. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):22-6.
    View in: PubMed
    Score: 0.017
  37. Bone marrow transplantation for sickle cell anemia. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):86-9.
    View in: PubMed
    Score: 0.017
  38. Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon. Pediatr Blood Cancer. 2014 Aug; 61(8):1472-5.
    View in: PubMed
    Score: 0.017
  39. Spiny follicular hyperkeratotic papules on the face. JAMA Pediatr. 2013 Sep; 167(9):867-8.
    View in: PubMed
    Score: 0.016
  40. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol. 2013 Jul; 35(5):356-60.
    View in: PubMed
    Score: 0.016
  41. Complete heart block in a patient with acute lymphoblastic leukaemia: teicoplanin as a possible cause and review of literature. J Clin Pharm Ther. 2013 Apr; 38(2):156-8.
    View in: PubMed
    Score: 0.016
  42. Rhabdomyosarcoma treatment and outcome at a multidisciplinary pediatric cancer center in Lebanon. Pediatr Hematol Oncol. 2012 May; 29(4):322-34.
    View in: PubMed
    Score: 0.015
  43. Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol. 2011 Sep; 45(3):155-8.
    View in: PubMed
    Score: 0.014
  44. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
    View in: PubMed
    Score: 0.014
  45. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.014
  46. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. Pediatr Hematol Oncol. 2009 Sep; 26(6):439-47.
    View in: PubMed
    Score: 0.012
  47. Abdominal complications of chemotherapy in pediatric malignancies: imaging findings. Clin Imaging. 2009 Jul-Aug; 33(4):253-60.
    View in: PubMed
    Score: 0.012
  48. Familial infantile pyknocytosis in association with pulmonary hypertension. Pediatr Blood Cancer. 2008 Aug; 51(2):290-2.
    View in: PubMed
    Score: 0.012
  49. Addition of ketamine to propofol for initiation of procedural anesthesia in children reduces propofol consumption and preserves hemodynamic stability. Acta Anaesthesiol Scand. 2008 Apr; 52(4):561-5.
    View in: PubMed
    Score: 0.011
  50. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics. 2008 Feb; 39(1):46-50.
    View in: PubMed
    Score: 0.011
  51. Autoimmune neutropenia of childhood. Crit Rev Oncol Hematol. 1987; 7(1):37-51.
    View in: PubMed
    Score: 0.010
  52. Assessing procedural pain in children with cancer in Beirut, Lebanon. J Pediatr Oncol Nurs. 2006 Nov-Dec; 23(6):311-20.
    View in: PubMed
    Score: 0.010
  53. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006; 30(2):165-70.
    View in: PubMed
    Score: 0.010
  54. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J Pediatr. 1985 Oct; 107(4):537-41.
    View in: PubMed
    Score: 0.010
  55. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.008
  56. Report of a child with vitiligo and Evans syndrome. J Pediatr Hematol Oncol. 2003 Apr; 25(4):344-5.
    View in: PubMed
    Score: 0.008
  57. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.007
  58. Use of amphotericin B colloidal dispersion in children. J Pediatr Hematol Oncol. 2000 May-Jun; 22(3):242-6.
    View in: PubMed
    Score: 0.007
  59. Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication. Arch Dis Child. 2000 Feb; 82(2):165-8.
    View in: PubMed
    Score: 0.006
  60. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):389-96.
    View in: PubMed
    Score: 0.006
  61. Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection. 1999 May-Jun; 27(3):173-6.
    View in: PubMed
    Score: 0.006
  62. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
    View in: PubMed
    Score: 0.006
  63. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
    View in: PubMed
    Score: 0.006
  64. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
    View in: PubMed
    Score: 0.005
  65. Progressive autologous graft-versus-host disease induced by cyclosporin A. Bone Marrow Transplant. 1996 Sep; 18(3):659-62.
    View in: PubMed
    Score: 0.005
  66. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
    View in: PubMed
    Score: 0.005
  67. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.005
  68. Opsoclonus-myoclonus and recurrent neuroblastoma. J Pediatr. 1995 May; 126(5 Pt 1):847-8.
    View in: PubMed
    Score: 0.005
  69. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology. 1993 Apr; 187(1):45-9.
    View in: PubMed
    Score: 0.004
  70. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989 06 15; 320(24):1574-80.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.